Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally ...
Masimo (Nasdaq: MASI) reported third quarter revenue increased 5.4% to $504.6 million, surpassing the Zacks Consensus ...
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
Masimo stock broke out, touching an eight-month high Monday after the company said it could potentially separate its audio and consumer-facing business. Please watch the video at Investors.com ...
Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...
Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Nabaparna Bhattacharya Masimo Surges 8.7%: Is This an Indication of Further Gains? Masimo (NASDAQ: MASI) shares soared 8.7% in the last trading session to close at $121.42. The move was backed by ...
4-7 Masimo SET ® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world, 8 and is the ... devices like Rad-67 ®, fingertip ...
Good afternoon, ladies and gentlemen, and welcome to Masimo's third-quarter 2024 earnings conference call. The company's press release is available at www.masimo.com. (Operator Instructions ...
Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review ...